Cite
HARVARD Citation
Iguchi, H. et al. (n.d.). 530 A phase II study of cancer vaccination using three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study). European journal of cancer. pp. S114-. [Online].